LFMDLifeMD, Inc.

$200M

Q2 2019 Earnings

Healthcare Medical - Pharmaceuticals

Income Statement

Revenue

$3M+32.4% YoY

Gross Profit

$2M75.7% margin

Operating Income

-$833,165-30.9% margin

Net Income

-$818,104-30.3% margin

EPS (Diluted)

$-0.09

QoQ Revenue Growth

-0.0%

Cash Flow

Operating Cash Flow

$93,718

Free Cash Flow

$93,718

Stock-Based Comp.

$218,460

Balance Sheet

Total Assets

$2M

Total Liabilities

$4M

Stockholders' Equity

-$2M

Cash & Equivalents

$265,107

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$2M	+32.4%
Gross Profit	$2M	$2M	+35.9%
Operating Income	-$833,165	-$597,493	-39.4%
Net Income	-$818,104	-$607,032	-34.8%

LFMD Q2 2019 Earnings — LifeMD, Inc. Revenue & Financial Results | Market Cap Arena